AGA Abstracts
1161 Adalimumab Prevents Post-Operative Crohn's Disease Recurrence, and is Superior to Thiopurines: Early Results From the POCER Study

https://doi.org/10.1016/S0016-5085(12)60794-XGet rights and content

References (0)

Cited by (0)

View full text